CD274 and neoplasm: The enrolment was irrespective of PD-L1 expression; 47.9% had PD-L1 positivity, defined as a more than 10% in a combined positive score (CPS) number of PD-L1-positive cells (tumor cells, macrophages, and lymphocytes) divided by the total number of tumor cells, multiplied by 100.